Glimisung PM 1mg/500mg/15mg Tablet SR
Marketer
Neoliva Formulations
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimisung PM 1mg/500mg/15mg Tablet SR
Metformin/Glibenclamide/Pioglitazone extended-release tablets (1mg/500mg/15mg) manage blood glucose in adults with type 2 diabetes. Used alongside diet and exercise, this combination therapy enhances insulin effectiveness, reducing blood sugar. Follow your doctor's prescribed dosage and frequency; take with food to minimize stomach discomfort. If a dose is missed, take it promptly unless the next dose is imminent; never double the dose. Overdosing can cause dangerously low blood sugar (hypoglycemia). Hypoglycemia may occur with concurrent antidiabetic medications, alcohol consumption, or missed meals; regular blood glucose monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Before starting treatment, disclose any kidney, liver, or heart conditions to your physician. Pregnant or lactating individuals require medical consultation. Kidney function will be assessed prior to treatment initiation. Limit alcohol consumption to reduce side effect risk.
Uses of Glimisung PM 1mg/500mg/15mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Glimisung PM 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or dividing it. The Glimisung PM 1mg/500mg/15mg Extended-Release tablet should be administered with a meal.
Common Side effects of Glimisung PM 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimisung PM 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Glimisung PM 1mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.
How Glimisung PM 1mg/500mg/15mg Tablet SR works:
Glimisung PM 1mg/500mg/15mg Extended-Release Tablets contain glimepiride, metformin, and pioglitazone, three distinct antidiabetic agents. These medications employ diverse mechanisms to optimize blood glucose management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimisung PM 1mg/500mg/15mg SR tablets with alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
Using Glimisung PM 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimisung PM 1mg/500mg/15mg tablet likely poses a risk during lactation. Available human data indicate potential transfer to breast milk with the possibility of infant harm.
DrivingCAUTION
Impaired driving may result from excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glimisung PM 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimisung PM 1mg/500mg/15mg SR tablets. Physician consultation is essential. Kidney function should be regularly monitored during treatment.
LiverCAUTION
Patients with liver impairment should use Glimisung PM 1mg/500mg/15mg SR tablets cautiously, potentially requiring dose modification. Physician consultation is advised. Glimisung PM 1mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimisung PM 1mg/500mg/15mg Tablet SR :
Should you forget a dose of Glimisung PM 1mg/500mg/15mg Extended-Release Tablet, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed one and resume your usual regimen. Never take a double dose.
Facts to Know About Glimisung PM 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently